GCGR

There are 194 papers on GCGR in aging research: 54 trials and 4 observational studies in people, 17 in animals, 3 in cells, 110 reviews. The newest story, Nov 9, 2026: “Efinopegdutide helped resolve inflammatory liver disease”.

Gene

194 papers study it16 findings

HGNCNCBI GeneTaxon

25 new papers in 30 daysSee all 194 papers on GCGR

At a glance

The findings reach mice, none yet in people; independent labs found the same change in mice. 5 independent labs in 3 countries; 152 trials, 27 with no results posted.

1 of its findings points the other way.

Mice: replicated by independent labs. Cells: a single group. Worms or flies and humans: nothing yet.
  • 5 independent labs in 3 countries
  • 1 finding against
  • 152 trials, 27 with no results posted
  • Funders: National Institute on Aging and others
  • 5 of 15 findings with company ties
  • 138 of 152 trials sponsored by developers of drugs aimed at it
  • Human trial54
  • Humans4
  • Animals17
  • Cells3

Interventions

2

Endurance exercise training

downin rats1

1 study
  1. Endurance exercise training decreases GCGR in rats (sex- and tissue-specific changes).

    “Endurance training elicited sex- and tissue-specific changes in incretin receptor expression, including downregulation of Gcgr across brown adipose, adrenal glands, and white adipose tissue (WAT).”

    Animalssex- and tissue-specific changestreadmillbrown adipose tissue; adrenal gland; white adipose tissue

    The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues

    Physiological genomics

More on Endurance exercise training

Mazdutide

upin humans1

1 study
  1. Mazdutide activates GCGR in humans.

    “Mazdutide (Xinermei®) is a dual glucagon receptor (GcgR) and glucagon-like peptide-1 receptor (GLP-1R) agonist”

    Review

    Mazdutide: First Approval

    Drugs

More on Mazdutide

Effects

11

Lifespan

upin mice2no changein mice1−35% median lifespan on knockout

2 studies
  1. GCGR showed no clear effect on lifespan in mice (shown by liver-specific knockout).

    “male LKO mice exhibited normal lifespan”

    Animalsshown by liver-specific knockoutlivermales

    Uncoupling Insulin Sensitivity From Longevity: A Sex-Dependent Effect of Hepatic Glucagon Signaling

    Aging cell

  2. GCGR extends lifespan in mice (shown by liver-specific knockout).

    “female LKO mice displayed a significant reduction in survival”

    Animalsshown by liver-specific knockoutliverfemales

    Uncoupling Insulin Sensitivity From Longevity: A Sex-Dependent Effect of Hepatic Glucagon Signaling

    Aging cell

  3. GCGR extends lifespan in mice (shown by global knockout (Gcgr KO); median lifespan lost by 35% in lean mice) (-35% median lifespan on knockout).

    “We found that globally eliminating glucagon receptor signaling (Gcgr KO) decreases median lifespan by 35% in lean mice.”

    Animalsshown by global knockout (Gcgr KO); median lifespan lost by 35% in lean micemales

    Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

    GeroScience

Inflammation

downin mice1

1 study
  1. GCGR decreases inflammation in mice (shown by liver-specific knockout in aged mice).

    “a striking, female-specific activation of pro-inflammatory pathways, notably NF-κB and cGAS-STING signaling, in the liver and kidney of aged LKO mice”

    Animalsshown by liver-specific knockout in aged miceliver and kidneyfemales

    Uncoupling Insulin Sensitivity From Longevity: A Sex-Dependent Effect of Hepatic Glucagon Signaling

    Aging cell

More on Inflammation

AMPK activation

upin mice1

1 study
  1. GCGR activates AMPK activation in mice (shown by liver-specific deletion; regardless of diet).

    “Liver-specific deletion of the glucagon receptor decreases hepatic AMP kinase activation in aging mice, regardless of diet.”

    Animalsshown by liver-specific deletion; regardless of dietliver

    Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

    GeroScience

Metabolic response to chronic caloric restriction

is required forin mice1

1 study
  1. GCGR is required for metabolic response to chronic caloric restriction in mice (shown by global knockout (Gcgr KO) with chronic caloric restriction).

    “glucagon receptor signaling is indispensable to the metabolic response to chronic CR in young and aged mice”

    Animalsshown by global knockout (Gcgr KO) with chronic caloric restriction

    Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

    GeroScience

ANGPTL3/8 secretion

is required forin human cells1

1 study
  1. GCGR is required for ANGPTL3/8 secretion in human cells.

    “these reductions were blocked with the GCGR antagonist antibody”

    Cellsshown by GCGR antagonist antibody block of retatrutide and glucagon effects in primary human hepatocyteshepatocyte

    Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids

    Diabetes, obesity & metabolism

More on ANGPTL3/8 secretion

ANGPTL3/8

is required forin cells1

1 study
  1. GCGR is required for ANGPTL3/8 in human hepatocytes.

    “In the absence of insulin, glucagon and retatrutide decreased hepatocyte ANGPTL3/8 secretion to 50.3% and 45.4% of control, respectively, and these effects were blocked by the GCGR Ab.”

    Cellsin human hepatocytes

    Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids

    Diabetes, obesity & metabolism

More on ANGPTL3/8

AMPK signaling

upin mice1

1 study
  1. GCGR activates AMPK signaling in mice (shown by liver-specific deletion, regardless of diet).

    “Liver-specific deletion of the glucagon receptor decreases hepatic AMP Kinase activation in aging mice, regardless of diet.”

    Animalsshown by liver-specific deletion, regardless of dietlivermales

    Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

    bioRxiv : the preprint server for biologyPreprint

More on AMPK signaling

Metabolic response to caloric restriction

is required forin mice1

1 study
  1. GCGR is required for metabolic response to caloric restriction in mice.

    “glucagon receptor signaling is indispensable to the metabolic response to chronic CR in young and aged mice”

    Animalsrequired for the reductions in liver fat, serum triglyceride and serum cholesterol under caloric restrictionmales

    Glucagon receptor signaling is indispensable for the healthspan effects of caloric restriction in aging male mice

    bioRxiv : the preprint server for biologyPreprint

Pancreatic neuroendocrine tumor

no changein mice1

1 study
  1. GCGR showed no clear effect on pancreatic neuroendocrine tumor in mice (Gcgr V369M/V369M).

    “pancreatic neuroendocrine tumors (PNETs) did not manifest”

    AnimalsGcgr V369M/V369M

    Absence of PNET formation and normal longevity in a mouse model of Mahvash disease

    Heliyon

More on Pancreatic neuroendocrine tumor

Cholesterol

upin mice1

1 study
  1. GCGR increases cholesterol in mice (homozygous V369M mutation).

    “elevated the levels of cholesterol and low-density lipoprotein-cholesterol”

    Animalshomozygous V369M mutation

    Absence of PNET formation and normal longevity in a mouse model of Mahvash disease

    Heliyon

More on Cholesterol

All 11

Upstream

1

GHRH

downin mice1

1 study
  1. GHRH decreases GCGR in mice (GHRH knockout).

    “analysis of hepatic glucagon signaling showed a decrease in glucagon receptor expression and phosphorylated CREB”

    AnimalsGHRH knockoutliverfemales

    Distinct physiological characteristics and altered glucagon signaling in GHRH knockout mice: Implications for longevity

    Aging cell

More on GHRH

Latest

Dec 2025: 4Jan 2026: 5Feb 2026: 3Mar 2026: 11Apr 2026: 2May 2026: 0Jun 2026: 8Jul 2026: 5Aug 2026: 7Sep 2026: 9Oct 2026: 16Nov 2026: 1282 papers in 12 months
Lancet

Efinopegdutide helped resolve inflammatory liver disease

At 52 weeks, resolution without worsening liver scarring occurred in 56%, 63% and 61% at three efinopegdutide doses, versus 13% with placebo.At 52 weeks, resolution without worsening liver scarring occurred in 56%, 63% and 61% at three efinopegdutide doses, versus 13% with placebo.

Randomized trial in 381 peopleInterventions
Lancet

Survodutide met heart safety goal in adults with obesity

The combined cardiovascular outcome occurred in 3.7% on survodutide versus 4.1% on placebo over a median 22.0 months.The combined cardiovascular outcome occurred in 3.7% on survodutide versus 4.1% on placebo over a median 22.0 months.

Randomized trial · 5,507 peopleSurvodutide
The New England Journal of Medicine

Retatrutide cut knee osteoarthritis pain in obesity without diabetes

At 68 weeks, pain scores fell 3.96 points with 9-milligram retatrutide versus 2.12 with placebo on a scale from 0 to 10.At 68 weeks, pain scores fell 3.96 points with 9-milligram retatrutide versus 2.12 with placebo on a scale from 0 to 10.

Randomized trial · 445 peopleRetatrutide

See all 194 papers on GCGR